Circulating extracellular vesicles as novel biomarkers for pulmonary arterial hypertension in patients with systemic lupus erythematosus
Findings reveal that specific subgroups of circulating EVs contribute to the hypercoagulation state and the severity of SLE-PAH. Higher plasma levels of LEVs or REVs may serve as biomarkers for SLE-PAH.
Authors
- Fumin Qi (ORCID: https://orcid.org/0000-0001-8432-5803)
- Ming‐Lin Liu (ORCID: https://orcid.org/0000-0001-8827-2024)
- Hou Hou
- Zhe Ding (ORCID: https://orcid.org/0000-0002-5604-7129)
- Zhouming Wang
- Wei Wei (ORCID: https://orcid.org/0000-0002-4386-8577)
- Na Zhang (ORCID: https://orcid.org/0000-0001-9534-0320)
- Li Liu (ORCID: https://orcid.org/0000-0001-5340-1551)
- Xiaomei Wang (ORCID: https://orcid.org/0000-0002-0907-575X)
- Jun Du
- Ying Guo (ORCID: https://orcid.org/0000-0002-5836-1816)
- Xing Lyu
- Haoming Song
- Wenwen Sun (ORCID: https://orcid.org/0000-0003-2657-2536)
Institutions
- Tongji University (CN)
- Tianjin Medical University General Hospital (CN)
- Philadelphia VA Medical Center (US)
- Tongji Hospital (CN)
- University of Pennsylvania (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.3389/fimmu.2024.1374100
- Citations
- 5
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Lupus Research Alliance
- Tianjin Municipal Health Commission
- National Natural Science Foundation of China
- Tianjin Medical University